AI and the Future of Cancer Research

Episode 35

0:00-32:52

In this eye-opening episode of Life Science Solutions, Chris Adkins sits down with Marcel Frenkel, PhD, CEO and Co-Founder of Ten63 Therapeutics—a biotech startup using AI and quantum physics to design drugs for the most elusive and "undruggable" cancer targets. Marcel shares the groundbreaking science behind Ten63’s BEYOND platform, which navigates a chemical space of 10⁶³ possible molecules to find solutions the pharmaceutical industry previously considered impossible. With personal insight from his mother’s cancer journey, Frenkel explains how traditional drug discovery fails patients—and how Ten63 is flipping the script. Whether you're in biotech, pharma, or just passionate about the future of AI in medicine, this episode is a powerful look into the next frontier of oncology and therapeutic innovation.

Publisher

Life Science Solutions

Link

share.transistor.fm/s/9a7bab78

Published

July 22, 2025

Duration

33 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

Host

Kymanox

LS

Life Science Solutions

@lifesciencesolutions

#future #cancerresearch #lifesciences

The Nile